Literature DB >> 7479737

Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution.

P Rubinstein1, L Dobrila, R E Rosenfield, J W Adamson, G Migliaccio, A R Migliaccio, P E Taylor, C E Stevens.   

Abstract

Clinical evidence of hematopoietic restoration with placental/umbilical cord blood (PCB) grafts indicates that PCB can be a useful source of hematopoietic stem cells for routine bone marrow reconstitution. In the unrelated setting, human leukocyte antigen (HLA)-matched donors must be obtained for candidate patients and, hence, large panels of frozen HLA-typed PCB units must be established. The large volume of unprocessed units, consisting mostly of red blood cells, plasma, and cryopreservation medium, poses a serious difficulty in this effort because storage space in liquid nitrogen is limited and costly. We report here that almost all the hematopoietic colony-forming cells present in PCB units can be recovered in a uniform volume of 20 ml by using rouleaux formation induced by hydroxyethyl starch and centrifugation to reduce the bulk of erythrocytes and plasma and, thus, concentrate leukocytes. This method multiples the number of units that can be stored in the same freezer space as much as 10-fold depending on the format of the storage system. We have also investigated the proportion of functional stem/progenitor cells initially present that are actually available to the recipient when thawed cryopreserved PCB units are infused. Progenitor cell viability is measurably decreased when thawed cells, still suspended in hypertonic cryopreservative solutions, are rapidly mixed with large volumes of isotonic solutions or plasma. The osmotic damage inflicted by the severe solute concentration gradient, however, can be averted by a simple 2-fold dilution after thawing, providing almost total recovery of viable hematopoietic progenitor cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7479737      PMCID: PMC40747          DOI: 10.1073/pnas.92.22.10119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  HLA-mismatched cord-blood transplantation in a patient with advanced leukemia.

Authors:  E Vilmer; G Sterkers; C Rahimy; E Denamur; J Elion; A Broyart; B Lescoeur; J M Tiercy; J Gerota; P Blot
Journal:  Transplantation       Date:  1992-05       Impact factor: 4.939

2.  Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling.

Authors:  E Gluckman; H A Broxmeyer; A D Auerbach; H S Friedman; G W Douglas; A Devergie; H Esperou; D Thierry; G Socie; P Lehn
Journal:  N Engl J Med       Date:  1989-10-26       Impact factor: 91.245

3.  Umbilical cord blood banking: evaluation of the collection procedure and of CFU-GM content.

Authors:  F Bertolini; C Corsini; E Lauri; F Gorini; G Sirchia
Journal:  J Hematother       Date:  1993

4.  Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells.

Authors:  H E Broxmeyer; G W Douglas; G Hangoc; S Cooper; J Bard; D English; M Arny; L Thomas; E A Boyse
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

5.  Growth of human umbilical-cord blood in longterm haemopoietic cultures.

Authors:  J M Hows; B A Bradley; J C Marsh; T Luft; L Coutinho; N G Testa; T M Dexter
Journal:  Lancet       Date:  1992-07-11       Impact factor: 79.321

6.  Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults.

Authors:  H E Broxmeyer; G Hangoc; S Cooper; R C Ribeiro; V Graves; M Yoder; J Wagner; S Vadhan-Raj; L Benninger; P Rubinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

7.  Adverse reactions in patients transfused with cryopreserved marrow.

Authors:  D F Stroncek; S K Fautsch; L C Lasky; D D Hurd; N K Ramsay; J McCullough
Journal:  Transfusion       Date:  1991 Jul-Aug       Impact factor: 3.157

8.  Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment.

Authors:  J E Wagner; H E Broxmeyer; R L Byrd; B Zehnbauer; B Schmeckpeper; N Shah; C Griffin; P D Emanuel; K S Zuckerman; S Cooper
Journal:  Blood       Date:  1992-04-01       Impact factor: 22.113

9.  Unrelated placental blood for bone marrow reconstitution: organization of the placental blood program.

Authors:  P Rubinstein; P E Taylor; A Scaradavou; J W Adamson; G Migliaccio; D Emanuel; R L Berkowitz; E Alvarez; C E Stevens
Journal:  Blood Cells       Date:  1994

10.  The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation.

Authors:  J Kurtzberg; M Graham; J Casey; J Olson; C E Stevens; P Rubinstein
Journal:  Blood Cells       Date:  1994
View more
  139 in total

1.  Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells.

Authors:  M Kanovsky; A Raffo; L Drew; R Rosal; T Do; F K Friedman; P Rubinstein; J Visser; R Robinson; P W Brandt-Rauf; J Michl; R L Fine; M R Pincus
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

2.  Re: Stem cells derived from cord blood in transplantation and regenerative medicine. Further phenomena.

Authors:  Andreas Sputtek
Journal:  Dtsch Arztebl Int       Date:  2010-04-23       Impact factor: 5.594

3.  Quality of long-term cryopreserved umbilical cord blood units for hematopoietic cell transplantation.

Authors:  Shohei Yamamoto; Hirokazu Ikeda; Daisuke Toyama; Mayumi Hayashi; Kousuke Akiyama; Manabu Suzuki; Yutaka Tanaka; Tsuneki Watanabe; Yoko Fujimoto; Ichirou Hosaki; Hirokazu Nishihira; Keiichi Isoyama
Journal:  Int J Hematol       Date:  2011-01-05       Impact factor: 2.490

4.  Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning.

Authors:  Junya Kanda; David A Rizzieri; Cristina Gasparetto; Gwynn D Long; John P Chute; Keith M Sullivan; Ashley Morris; Clayton A Smith; Donna E Hogge; Janet Nitta; Kevin Song; Donna Niedzwiecki; Nelson J Chao; Mitchell E Horwitz
Journal:  Biol Blood Marrow Transplant       Date:  2010-09-22       Impact factor: 5.742

5.  Donor-derived second hematologic malignancies after cord blood transplantation.

Authors:  Karen K Ballen; Corey Cutler; Beow Y Yeap; Steven L McAfee; Bimalangshu R Dey; Eyal C Attar; Yi-Bin Chen; Richard L Haspel; Deborah Liney; John Koreth; Vincent Ho; Edwin P Alyea; Robert J Soiffer; Thomas R Spitzer; Joseph H Antin
Journal:  Biol Blood Marrow Transplant       Date:  2010-02-21       Impact factor: 5.742

6.  Quality of umbilical cord blood CD34+ cells in a double-compartment freezing bag cryopreserved without a rate-controlled programmed freezer.

Authors:  Masayoshi Minegishi; Tsuneo Itoh; Narumi Fukawa; Tamie Kitaura; Junko Miura; Hiroyuki Takahashi; Akira Suzuki; Yoshinori Kudo; Ayuko Narita; Yuko Sato; Masakuni Suzuki; Takanori Watanabe; Yuichi Wada; Yoichi Takeyama; Shigeru Tsuchiya
Journal:  Int J Hematol       Date:  2007-01       Impact factor: 2.490

Review 7.  Cryopreservation of hematopoietic stem cells.

Authors:  David Berz; Elise M McCormack; Eric S Winer; Gerald A Colvin; Peter J Quesenberry
Journal:  Am J Hematol       Date:  2007-06       Impact factor: 10.047

8.  Expression of plasma membrane receptor genes during megakaryocyte development.

Authors:  Sijie Sun; Wenjing Wang; Yvette Latchman; Dayong Gao; Bruce Aronow; Jo-Anna Reems
Journal:  Physiol Genomics       Date:  2013-01-15       Impact factor: 3.107

9.  Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies.

Authors:  Jon J van Rood; Cladd E Stevens; Jacqueline Smits; Carmelita Carrier; Carol Carpenter; Andromachi Scaradavou
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

10.  Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution.

Authors:  Colleen Delaney; Shelly Heimfeld; Carolyn Brashem-Stein; Howard Voorhies; Ronald L Manger; Irwin D Bernstein
Journal:  Nat Med       Date:  2010-01-17       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.